Quarterly report pursuant to Section 13 or 15(d)

SUMMARY OF SIGNIFICANT ACCOUNTING POLICIES (Details)

v3.20.1
SUMMARY OF SIGNIFICANT ACCOUNTING POLICIES (Details) - USD ($)
3 Months Ended 12 Months Ended
Mar. 31, 2020
Mar. 31, 2019
Dec. 31, 2019
Dec. 30, 2019
SUMMARY OF SIGNIFICANT ACCOUNTING POLICIES (Details) [Line Items]        
Cash, Uninsured Amount $ 14,999,734 $ 11,608,582    
Inventory, Net 800,000   $ 577,690  
Research and Development Expense $ 4,926,714 $ 1,488,839    
Share-based Compensation Arrangement by Share-based Payment Award, Options, Outstanding, Number (in Shares) 3,828,896   3,980,804 3,980,804
Share-based Compensation Arrangement by Share-based Payment Award, Options, Vested, Number of Shares (in Shares) 2,730,112   2,874,017  
Amortization $ 4,751      
Patents [Member]        
SUMMARY OF SIGNIFICANT ACCOUNTING POLICIES (Details) [Line Items]        
Finite-Lived Intangible Asset, Useful Life     20 years